Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $ with a. Vertex Pharmaceuticals Inc (VRTX) ; Open: ; Day's Range: ; 52 wk Range: ; Volume: 1,, ; Average Vol. (3m): 1,, Vertex Pharmaceuticals Incorporated (VRTX) ; Jul 31, , , , , ; Jul 30, , , , , Volume, M. Market Value, $B. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. On Friday, Vertex Pharmaceuticals Inc (VRTX:NSQ) closed at , % below its week high of , set on Aug 01, week range. Today. Sep.
Vertex Pharmaceuticals Incorporated (old-picture.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vertex Pharmaceuticals. Vertex Pharmaceuticals · Open. · Previous Close. · High. · Low. · 52 Week High. · 52 Week Low. · Beta. · TTM EPS Trend. 46 minutes ago. Vertex Pharmaceuticals Incorporated's stock symbol is VRTX and currently trades under NASDAQ. It's current price per share is approximately $ When is. The official channel for Vertex Pharmaceuticals. old-picture.ru Pharmaceutical Company Boston, MA old-picture.ru Joined November 89 Following. See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Vertex Pharmaceuticals (NASDAQ: VRTX). $ (%). $ Price as of September 9, Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $ with a. Vertex Pharmaceuticals traded at $ this Monday September 9th, increasing $ or percent since the previous trading session. Looking back, over the. Year End Stock Prices · · · · · Year. The intrinsic value of one VRTX stock under the Base Case scenario is USD. Compared to the current market price of USD, Vertex Pharmaceuticals Inc is.
Get the latest updates on Vertex Pharmaceuticals Incorporated Common Stock (VRTX) pre market trades, share volumes, and more. Make informed investments with. Vertex Pharmaceuticals Inc VRTX:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High Stock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. The current price of VRTX is USD — it has increased by % in the past 24 hours. Watch Vertex Pharmaceuticals Incorporated stock price performance more. Discover real-time Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock prices, quotes, historical data, news, and Insights for informed trading. Vertex Pharmaceuticals Inc. · AT CLOSE PM EDT 09/06/24 · USD · % · Volume1,, Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases. The 94 analysts offering price forecasts for Vertex Pharmaceuticals have a median target of , with a high estimate of and a low estimate of Vertex Pharmaceuticals ; Market Cap. $B ; P/E Ratio (ttm). N/A ; Forward P/E · ; Diluted EPS (ttm). ; Dividends Per Share. N/A.
Are Investors Undervaluing Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) By 35%? Are Investors Undervaluing Vertex Pharmaceuticals Incorporated (NASDAQ. Vertex Pharmaceuticals Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - See VRTX stock price and Buy/Sell Vertex Pharmaceuticals. Discuss news and analysts' price predictions with the investor community. Vertex Pharmaceuticals Inc (VRTX) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. The all-time high Vertex Pharmaceuticals stock closing price was on August 01, · The Vertex Pharmaceuticals week high stock price is
(NASDAQ: VRTX) Vertex Pharmaceuticals currently has ,, outstanding shares. With Vertex Pharmaceuticals stock trading at $ per share, the total. The intrinsic value of one VRTX stock under the Base Case scenario is USD. Compared to the current market price of USD, Vertex Pharmaceuticals Inc is. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).